支气管镜肺体积减小线圈治疗严重肺气患者的结果
Ahmet Hamdi Ilgazlı1, Aykut Eliçora2, Hüseyin Fatih Sezer2
1Department of Chest Diseases, Medicine Faculty of Kocaeli University, Kocaeli, Türkiye.
Turk gogus kalp damar cerrahisi dergisi
|December 11, 2023
概括
支气管镜肺体积减小线圈治疗改善了严重肺的结果. 患者在手术后12个月表现出更好的肺功能和减少呼吸障碍,这表明这是一个有前途的治疗选择.
科学领域:
- 肺部医学 肺部医学
- 干预性肺病学 干预性肺病学
- 呼吸系统疾病研究 呼吸系统疾病研究
背景情况:
- 严重的肺气显著影响患者的生活质量.
- 目前严重肺气的治疗选择有局限性.
- 使用线圈的支气管镜肺体积减小 (BLVR) 是一种新兴的治疗方法.
研究的目的:
- 为了评估BLVR线圈治疗在严重肺气患者的有效性.
- 评估治疗后肺功能,运动能力和呼吸障碍的变化.
- 为了确定BLVR线圈治疗在12个月后的长期结果.
主要方法:
- 一组20名严重肺气患者接受了BLVR线圈治疗.
- 治疗前后的评估包括肺功能测试,6分钟的步行距离和MRC呼吸障碍得分.
- 在干预后6个月和12个月收集数据.
主要成果:
- 每个叶片中平均放置了12.0±3.8个线圈.
- 12个月后,肺功能测试和生活质量显著改善.
- 在12个月后 (p<0.05) 观察到呼吸障碍 (MRC得分) 的显著减少,在6个月后没有显著变化.
结论:
- BLVR线圈治疗对于严重的肺气是一种有前途的选择.
- 该程序导致肺功能和呼吸障碍得分的显著改善.
- 进一步的研究可以验证这些发现,并优化患者选择BLVR线圈疗法.
相关概念视频
Respiratory Volumes
1.5K
Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
1.5K
COPD: Management Using Bronchodilators and Corticosteroids
213
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
213
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Pneumothorax-II
156
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
156
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Acute Respiratory Failure-V
142
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
142


